ASCO® 2024 Insights: "PRGN-2012, a Novel Gorilla Adenovirus-Based IO, Provides the First Treatment That Leads to Complete & Durable Responses in Recurrent Respiratory Papillomatosis Patients"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PRGN-2012, a Novel Gorilla Adenovirus-Based IO, Provides the First Treatment That Leads to Complete & Durable Responses in Recurrent Respiratory Papillomatosis Patients"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Scott Norberg

68 views

June 7, 2024

0 Comments

2024 ASCO® Annual Meeting Insights Hub: Head & Neck Videos

19:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Tri…

Feat. K. Kerrigan

08:06

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor T…

Feat. D. Ziegler

07:58

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Analyses of TTX-080, a First-in-Class HLA…

Feat. S. Ulahannan

View All

Head & Neck Virtual Webinar Series #1

Thu, Sep 19, 2024

14:57

Penn Medicine

The Radiologist's Approach to Assessing Cancer Risk of Thyroid …

Feat. J. Langer

27:04

Fengting Yan

Cancer Screening Molecular Tools

21:12

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Ca…

Feat. N. Saba

29:25

Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae

27:51

Keck School of Medicine of USC

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Feat. R. Michael Tuttle

14:49

Vivek Subbiah

Year in Review: Precision Medicine

25:55

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "News in Head&Neck Cancers"

Feat. P. Bossi

26:19

Ammar Sukari

Nasopharyngeal Carcinoma: Clinical Overview & Disease Management

18:07

Nebraska Oncology Society

NOS ASCO® 2023 Review: Nasopharynx Cancer

Feat. E. Sherman

06:47

UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang

42:49

Yale Cancer Center

Parathyroid Disease and Tumors

Feat. C. Gibson

15:16

Penn Medicine

The Approach to a Patient with a Thyroid Nodule: Updating "The …

Feat. Z. Baloch

13:47

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…

Feat. V. Subbiah

13:06

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL…

Feat. P. Bossi

29:54

Jefferson Health

Recent Advances in Treatment of Thyroid Cancer With Precision Medici…

Feat. M. Brose

21:35

Jefferson Health

Thyroid Nodule Fine Needle Aspiration

Feat. J. Sheehan

12:02

Insights from 2023 IFHNOS Annual Meeting

IFHNOS 2023 Insights: "Personalized (Precision) Medicine in Hea…

Feat. C. Stratakis

12:25

GRACE

Incurable HPV- Head & Neck Cancer: Panel Discussion

Feat. J. Weiss, S. Patel, S. Sheth

28:06

Jefferson Health

Comprehensive Workup of Thyroid Nodules

Feat. R. Haddad

26:51

Paolo Bossi

Login

Login

Join VuMedi

ASCO® 2024 Insights: "PRGN-2012, a Novel Gorilla Adenovirus-Based IO, Provides the First Treatment That Leads to Complete & Durable Responses in Recurrent Respiratory Papillomatosis Patients"

2024 ASCO® Annual Meeting Insights Hub: Head & Neck Videos

Related Content